trial · primary record
AB598
Advanced Cancer
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-09 |
| Primary endpoint | Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT05891171 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:34.879Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05891171
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.